Depression studies

Hypericum-Extrakt Ze 117 (Zeller AG): Klinische Studie zur Verminderung von Rückfällen bei Patienten mit Depression nach DSM-IV (Mittelschwere Major Depression: einzeln/rezi- divierend)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany

Sponsor

Max Zeller Söhne AG

Ketamine as an adjunctive therapy for Major Depression (2) - a randomised controlled trial

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Ireland

Sponsor

Trinity College Dublin

LIVELIFE: effectiveness of two types of support for low mood

This study ended early.

Countries

United Kingdom

Sponsor

University of Exeter (UK)

Longitudinal imaging of serotonin transporter occupancy using PET and [11C]DASB in patients with major depression treated with escitalopram or citalopram

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria

Sponsor

Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien

Maternal Mental Health (MAMA) Study. Short time estrogen as a candidate strategy to prevent postpartum depression in a high-risk group

This study is no longer accepting new participants.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Countries

Denmark

Sponsor

Rigshospitalet

Optimal Duration of Olazapine Add-on therapy in Major Depression: A double-blind, placebo-controlled, randomized, Phase III, Pilot Study in parallel group Design

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany

Sponsor

Charité Universitätsmedizin Berlin

Relapse prevention in patients with major depression treated with electroconvulsive therapy using a fixed dose range of escitalopram compared to a fixed dose of nortriptyline (DUAG-7) A randomised ...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Denmark

Sponsor

Danish University Antidepressant Group (DUAG)

SAFETY AND EFFICACY OF CIMICOXIB, A SELECTIVE COX-2 INHIBITOR, IN COMBINATION WITH SERTRALINE COMPARED TO SERTRALINE COMBINED WITH PLACEBO IN TREATMENT OF MAJOR DEPRESSION

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Austria, Czechia, Germany

Sponsor

Affectis Pharmaceuticals AG

Simvastatin add-on to Escitalopram in patients with comorbid obesity and major depression: A multicenter, randomized, double-blind, placebo-controlled trial

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Germany

Sponsor

Charité – Universitätsmedizin Berlin

The Role of Negr1 In modulating Neuroplasticity in major depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

Countries

Italy

Sponsor

FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF SAGE-217 IN THE TREATMENT OF ADULTS WITH SEVERE POSTPARTUM DEPRESSION

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

United Kingdom

Sponsor

Sage Therapeutics, Inc.

Antidepressive response to add-on occupational therapy in patients with major depression: A randomized controlled multicentre trial

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

Countries

Germany

Sponsor

LWL University Hospital Bochum